Defense of Reglan pattern liability actions

August 2011

Drug Makers Look to Campbell Campbell Edwards & Conroy, P.C. for Mass Tort Defense. A total of more than 3,000 plaintiffs nationwide have already joined in the attack on the drug makers, alleging that they failed to warn of possible side effects of taking the drug, including Tardive dyskinesia, which is characterized by repetitive and involuntary movements, such as lip smacking, grimacing and rapid eye blinking.

“The U.S. Supreme Court has issued an opinion which could affect the outcome of this case, holding that drug warning claims are generally pre-empted by federal law,” says James M. Campbell, lead lawyer for the regional defense team.

The selection of Campbell, Campbell, Edwards & Conroy, P.C. as counsel reflects the firm’s reputation in the defense of medical products cases. A Fortune 100 drug company, a Fortune 100 medical device maker, and generic pharmaceutical manufacturers have all turned to the firm for sophisticated defenses in mass tort actions in recent years.